Market analysts have recently updated their ratings and price targets on shares of Abeona Therapeutics Inc. (ABEO). The latest reports which are currently in issue on Thursday 28th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
Abeona Therapeutics logo Abeona Therapeutics Inc (NASDAQ:ABEO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, AnalystRatingsNetwork.com reports. The firm ...
Broker Outlook For The Week Ahead Abeona Therapeutics Inc. (ABEO). By Brenton Akerman / in US Broker Ratings / on Tuesday, 26 Apr 2016 12:47 PM / 0 Comments. The most recently updated broker views and price targets issued for Abeona ...
The stock of Abeona Therapeutics Incorporated (NASDAQ:ABEO) registered a decrease of 0.57% in short interest. ABEO's total short interest was 1.44 million shares in April as published by FINRA. Its down 0.57% from 1.45M shares, reported previously.
Abeona Therapeutics logo Abeona Therapeutics Inc (NASDAQ:ABEO) has been given an average recommendation of “Buy” by the six brokerages that are presently covering the stock, ARN reports. Six analysts have rated the stock with a buy ...
Out of 4 analysts covering Abeona Therapeutics (NASDAQ:ABEO), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Abeona Therapeutics has been the topic of 2 analyst reports since December 16, 2015 according to StockzIntelligence ...